GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

A new study is set to test a vaccine looking to protect against a disease caused by two different types of Salmonella bacteria. The Oxford Vaccine Group has launched the BiVISTA study to evaluate ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

UK oncology researchers have come together to write the first-ever national thought leadership strategy report into cancer ...

Oxford University and pharmaceutical giant GSK are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target cells at ...

Scientists behind the Oxford Covid jab are developing a bubonic plague vaccine amid fears a superbug strain of the Black Death could emerge. There is no vaccine in the UK for the plague ...

Scientists from the Oxford Vaccine Group want to understand more about this relapsing infection in the months after a person is initially infected through the bite of a mosquito. In order to do so ...